Pharmaceuticals (Jun 2024)

Non-Apoptotic Programmed Cell Death as Targets for Diabetic Retinal Neurodegeneration

  • Yingjia Lin,
  • Shuping Ke,
  • Weiqing Ye,
  • Biyao Xie,
  • Zijing Huang

DOI
https://doi.org/10.3390/ph17070837
Journal volume & issue
Vol. 17, no. 7
p. 837

Abstract

Read online

Diabetic retinopathy (DR) remains the leading cause of blindness among the global working-age population. Emerging evidence underscores the significance of diabetic retinal neurodegeneration (DRN) as a pivotal biomarker in the progression of vasculopathy. Inflammation, oxidative stress, neural cell death, and the reduction in neurotrophic factors are the key determinants in the pathophysiology of DRN. Non-apoptotic programmed cell death (PCD) plays a crucial role in regulating stress response, inflammation, and disease management. Therapeutic modalities targeting PCD have shown promising potential for mitigating DRN. In this review, we highlight recent advances in identifying the role of various PCD types in DRN, with specific emphasis on necroptosis, pyroptosis, ferroptosis, parthanatos, and the more recently characterized PANoptosis. In addition, the therapeutic agents aimed at the regulation of PCD for addressing DRN are discussed.

Keywords